A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors

Clinical trial NCT06717022 · RECRUITING

Trial details

NCT number: NCT06717022
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Mesothelin Positive Tumors

Start date: 2024-05-06
Primary completion: 2026-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.